Feb 12 (Reuters) - Mayne Pharma Group Ltd
* Mayne Pharma announces acquisition of lorcet & esgic
* Says acquired selected brands from forest laboratories, inc for US$10.0 million plus a US$2.0 million performance-based earn
* Says will fund the acquisition via a fully underwritten equity placement of A$18.0 million
* Says acquisition expected to be mid-single digit EPS accretive (pre-synergies) in its first full financial year
* Source text for Eikon
* ((For more news, please click here
((Bangalore Newsroom; +91 80 6749 1130))